From Company Creation through Public Investing
The Frazier Life Sciences team invests in and builds companies developing and commercializing novel therapeutics.
Frazier Healthcare Partners Closes Oversubscribed $830 Million Life Sciences Public Fund
Frazier Healthcare Partners Announces Several Promotions on Life Sciences Team
Frazier Healthcare Partners Adds Highly Experienced Biopharmaceutical Executive to Life Sciences Team
Takeda and Frazier Healthcare Partners Announce Collaboration to Launch HilleVax, Inc. to Develop Clinical Stage Norovirus Vaccine Candidate
